Your search
Results 65 resources
-
Prevention of infection is important in the susceptible patients undergoing transplantation. Accurate diagnosis continues to be a challenge, and response to treatment is often suboptimal, mainly due to immune defects that cannot be corrected during the course of an infection episode. Antimicrobial drugs are the cornerstone for prevention of opportunistic and other routinely encountered infections in patients undergoing solid organ and hematopoietic stem cell allograft transplantation....
-
Endemic fungi are thermally dimorphic and occur naturally in specific geographic areas. Histoplasmosis, coccidioidomycosis, and blastomycosis are the three major disease entities encountered in North America. Even in endemic areas, disease incidence is low among transplant recipients. Infection is typically acquired via inhalation of molds from the environment. Disseminated infection is more likely to occur in immunocompromised individuals. Definitive diagnosis is established by growing the...
-
Enterobacteriaceae comprise important pathogens for recipients of solid organ and hematopoietic stem cell transplants. Especially common in the early posttransplant period when transplant recipients are still hospitalized, they can occur at any time following the procedure. Increasing frequency of colonization and invasive disease due to antimicrobial-resistant pathogens has been described in recipients of solid organ and hematopoietic stem cell transplants. In solid organ transplant...
-
Hematopoietic stem cell transplantation (HSCT) has the potential to provide long-term survival and potential cure in patients with hematological malignancies and nonmalignant hematologic and autoimmune disorders. Conditioning regimens are designed to make room for the stem cell allograft by ablation of hosts’ immune system with the objective of sustained foreign immune cell engraftment. However, a number of short-term and long-term complications are associated with regimens used for...
-
Acute bloodstream infection (BSI) is one of the most severe forms of infection. BSI may be primary or secondary and community-acquired or healthcare-associated. BSI is frequently observed among immunocompromised and critically ill patients, but is rarely asymptomatic and may be associated with multiple organ failure (Pittet et al. JAMA. 1994;271(20):1598–601; Edmond et al. Clin Infect Dis. 1999;29(2):239–44; Marshall et al. Crit Care Med. 2003;31(5):1560–7). Infective endocarditis (IE) is...
Filter by our tag
ORGANISMS
-
BACTERIA
(8)
- C. difficile (1)
- MDR GNR (2)
- MRSA (1)
- Nocardia (1)
- Non-tuberculous Mycobacteria (2)
- Tuberculosis (2)
- VRE (1)
-
FUNGI
(5)
- Aspergillus (1)
- Candida (1)
- Cryptococcus (1)
- Dimorphic mycoses (1)
- Mucormycosis (1)
-
PARASITES AND PROTOZOA
(1)
- Toxoplasmosis (1)
-
VIRUSES
(7)
- Arboviruses (1)
- CMV (1)
- Hepatitis A (1)
- Hepatitis B (1)
- Hepatitis C (1)
- HHV-6 (1)
- HHV-8 (1)
- Measles (1)
- Parvovirus B19 (1)
- Respiratory Viruses (1)
- VZV (1)
- WNV (1)
DIAGNOSTICS
- Advanced Diagnostics (1)
- Fungal diagnostics (1)
- Viral diagnostics (1)
DRUGS AND THERAPIES
- Antibiotics (2)
- Antifungals (1)
- Antivirals (1)
- Stewardship (1)
PREVENTION
- Infection Control (1)
- Safe Living (1)
- Vaccination (1)
SYNDROMES AND CONDITIONS
- CNS (1)
- Cytopenias (1)
- Diarrhea (2)
- Endovascular infections (2)
- Pneumonia (1)
HEME-ONC AND CELLULAR THERAPIES
- BMT-specific ID (1)
- Neutropenia (1)
- PTLD (1)